NCT02289742

Brief Summary

The purpose of this study is to evaluate the pre lens tear film characteristics of DAILIES® Aqua Comfort Plus® Multifocal (DACP MF) and Toric (DACP Toric) compared to DAILIES® Aqua Comfort Plus® Sphere (DACP) daily disposable contact lenses over 12 hours of lens wear.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2014

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 10, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 13, 2014

Completed
18 days until next milestone

Study Start

First participant enrolled

December 1, 2014

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

July 26, 2016

Completed
Last Updated

July 26, 2016

Status Verified

June 1, 2016

Enrollment Period

3 months

First QC Date

November 10, 2014

Results QC Date

March 31, 2016

Last Update Submit

June 15, 2016

Conditions

Keywords

Dailies AquaComfort Plus® Multifocal (DACP MF)Dailies AquaComfort Plus® Toric (DACP Toric)tear film stabilityNon-Invasive Keratograph Break-Up Time (NIK-BUT)

Outcome Measures

Primary Outcomes (1)

  • Percentage of Subjects With Wettability Grade of 2 or 3 After 12 Hours of Wear

    A video was made to capture a visual demonstration of tear film characteristics in between blinks. The investigator graded contact lens surface wettability using a scale from 0 (fully wettable) to 3 (clearly visible distortions) at 5, 10, 15, 20 and 25 seconds post-blink by region (central, superior, nasal, inferior, and temporal). Three independent measurements (3 blinks) were carried out. An average was taken over the 3 measurements, 5 regions, and 5 time points. One eye contributed to the analysis.

    Hour 12, each product

Secondary Outcomes (1)

  • Percentage of Subjects With Wettability Grade of 2 or 3 After 8 Hours of Wear

    Hour 8, each product

Study Arms (2)

Arm1: Presbyopes

OTHER

Nelfilcon A contact lenses (multifocal and sphere) worn as randomized in a crossover design during Periods 1 and 2, with nelfilcon A sphere contact lenses in Period 3. Each product worn bilaterally (in both eyes) for 12 hours.

Device: Nelfilcon A multifocal contact lensesDevice: Nelfilcon A sphere contact lenses

Arm2: Astigmats

OTHER

Nelfilcon A contact lenses (toric and sphere) worn as randomized in a crossover design during Periods 1 and 2, with nelfilcon A sphere contact lenses in Period 3. Each product worn bilaterally (in both eyes) for 12 hours.

Device: Nelfilcon A toric contact lensesDevice: Nelfilcon A sphere contact lenses

Interventions

Also known as: DAILIES® AquaComfort Plus® Multifocal, DACP MF
Arm1: Presbyopes
Also known as: DAILIES® AquaComfort Plus® Toric, DACP Toric
Arm2: Astigmats
Also known as: DAILIES® AquaComfort Plus®, DACP
Arm1: PresbyopesArm2: Astigmats

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must sign an informed consent document;
  • Adapted, current soft contact lens wearer with either:
  • A spectacle add between +0.50 and +2.50 (inclusive) \[Presbyopes group\]
  • A spherical correction of an astigmatism up to 20% of the amount of the sphere \[Astigmats group\];
  • Contact lens prescription in the power range specified in the protocol;
  • Vision correctable to 0.2 logMAR (logarithmic minimal angle for resolution) or better in each eye at distance with pre-study lenses or manifest refraction at Visit 1;
  • Willing to wear study lenses up to 12 hours and attend all study visits;
  • Can be successfully fitted with study lenses;

You may not qualify if:

  • Any ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear;
  • Use of systemic or ocular medications for which contact lens wear could be contraindicated as determined by the investigator;
  • Use of artificial tears and rewetting drops during the study;
  • Monocular (only 1 eye with functional vision) or fit with only 1 lens;
  • Any abnormal ocular condition observed during the Visit 1 slit-lamp examination;
  • History of herpetic keratitis, ocular surgery, or irregular cornea;
  • Pregnant or lactating;
  • Unstable tear film with a NIK-BUT value below 8 seconds in either eye without lenses;
  • Participation in any clinical study within 30 days of Visit 1;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Refractive Errors

Condition Hierarchy (Ancestors)

Eye Diseases

Results Point of Contact

Title
Global Medical Affairs, Brand Lead - Vision Care
Organization
Alcon Research, Ltd.

Study Officials

  • Sr. Clinical Manager, Global Med Affairs, Operations

    Alcon Research

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 10, 2014

First Posted

November 13, 2014

Study Start

December 1, 2014

Primary Completion

March 1, 2015

Study Completion

March 1, 2015

Last Updated

July 26, 2016

Results First Posted

July 26, 2016

Record last verified: 2016-06